{"name":"ReNeuron Limited","slug":"reneuron-limited","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE96WVljUURSekpid0xBcnprX3cycjJ1RnZIeENvSXBNN3FuVXNDb0RiYXJiNi12ZERZTVQxSzhCMmlDLVBsMUEwc3VVdVdDSi1JY0V2eU02M201SEZ6?oc=5","date":"2026-03-05","type":"deal","source":"EurekAlert!","summary":"ReNeuron establishes new base at Swansea University’s Institute of Life Science in major research partnership - EurekAlert!","headline":"ReNeuron establishes new base at Swansea University’s Institute of Life Science in major research partnership - EurekAle","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQV1h1bkFNOHlDdDVQRkpNWDlWd1BWQjJOemFqUXF5ZVN2NnN1THFrVl9wXzZqUnF3QnZnRGhObE5MZFhkYm8tNEN0UXBZVDZxbm1oeFhOYmRVWFdKS0Z4MmZqQnYyM0RuZXNZRWpYRkxBM1M1d1VwSFotLVQySUhyaDZWQ25FT1M5RENjdUZsaFF1cV9RZlpBMNIBngFBVV95cUxOeUNRQm83ZWZnTlB1OXZ1YXNrYi01d05xb2s0cklnTDdlMVNyUGhZMlhvSDlIT2Q0SzhCMEpxS0F4QlFzcnRRS2JnV2cxSWhXcHM5U2pKUkI1UUdxMGpBNzhmcFdwQjhjeUVTS3FPUFhvVzZOeml3dGFiWTJhU3hJNlNmX1NZX05CXzlZMnQxb3lkYkxLN0dsYUx3cm1DQQ?oc=5","date":"2026-01-16","type":"pipeline","source":"Wales Online","summary":"The extraordinary £10bn success story Wales missed out on - Wales Online","headline":"The extraordinary £10bn success story Wales missed out on","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5Lc3NBRFQ1MnJSVEFBaVFndGNHZWN3Y3dtNkNsVEFPTDJjNW8tTUNTV0NIY19lY25wNW1yRk9UdVlIa3J2RG5CREVQOFZNdVlaNFNGZ3VIalJzT0pUN2RJ?oc=5","date":"2025-10-02","type":"pipeline","source":"PharmaTimes","summary":"Olav Hellebø - PharmaTimes","headline":"Olav Hellebø","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPMTJaWW4wRGREMUNPUkI1Tnl1OW1yeEdBUEdjZ2VUVDZPb2l3RHg5VkdCMHlkTEhCWmRMZmVIbmtMSXU0S3pPdFBIVkNrWkFON1oyZTVXUTZqcjNneDc4TzNpNEgyX1hESkExRlota1lEUk00UHc1VzFmOWRZLUgzakxpRjhkaHp1YU5OdFBZQlIzd1oyNEhLVE1B?oc=5","date":"2025-03-24","type":"pipeline","source":"businesscloud.co.uk","summary":"PLC emerges from year-long administration as private company - businesscloud.co.uk","headline":"PLC emerges from year-long administration as private company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxObVlxc3U4MFpkUTZaMmVVWTFRVmV0dkxWei1lUF9qdTJNMGpIaTREdFJQTlZzWVBTMFJBRlF5YXpWX1k2ak5NT2J3elIwLUMtOFUtZGF1ZzFmYVIyaWd2Z3pmMzdTb1FqSjhZemdLaUlnRVQxMlRta0cyMGI0Uko5c2pwWEdUQ1ZzV1BZ0gGQAUFVX3lxTE02UWVvN05VYTI4cjVKWTlCMEtjR2hIX2IyQ1NtVTlVOTV0WTdSMzhFUDM1YnM5VDlMM2N6d052R2tPTWRvVWVXZVQ3Vk5kY05KbVNDNkZtamV3ckw3eDhmQWVKWjVHZXZDNWJMMEUwTGR5QVJJRTc5ckc0R05wNm00TWVHc3F4cm1kMmhxdmIweg?oc=5","date":"2024-11-12","type":"pipeline","source":"BioInformant","summary":"Are Cell Therapy Companies Prioritizing Autologous Or Allogeneic Therapies? - BioInformant","headline":"Are Cell Therapy Companies Prioritizing Autologous Or Allogeneic Therapies?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNR0ZTdE1qZzdsTnJWa1o5RzVBMl96R19panZrLTdabHZWTjV3S0xucEs2RlpnTGdDQkREWlFOOEY0U1hhclhUQWlZWXQxZGZ2YXN0UHR6UHphWE93TklzRHdiSE9jcVdwdGd5VlU5cmE2bkc0UW9KM1l1VEtGNmM3SU5JM05kZGtteV90MVQzalJzMTFROG9GVDhBWmdETFBUVDJ1dXd3?oc=5","date":"2024-08-30","type":"pipeline","source":"Fierce Biotech","summary":"ReNeuron joins exodus from AIM exchange after missing fundraising goal - Fierce Biotech","headline":"ReNeuron joins exodus from AIM exchange after missing fundraising goal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxNaXM4STZKLVdXNGIxT0NtWTVVR1AyLXV1Tm9uSlRjRlJuVDlVa0huT1lBTjBYVXpHSTJnTDQ4SXlfcERneG9GQWpZWFlmRFQ5VVFpSEVWUlNfRk5VZ1A3RDYxTVNzNjZRZ1JTcDJqTlM1dzhhS3NyazBBVzBYVFBXNW9uQV9FN3c?oc=5","date":"2024-08-30","type":"pipeline","source":"pharmaphorum","summary":"UK biotech ReNeuron quits AIM as financing push fails - pharmaphorum","headline":"UK biotech ReNeuron quits AIM as financing push fails","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPT3F3VmlHU19yTEl3amJMaERuc0paRDRiMTY1azZqNkxkN3Q3V1BDUnBGdExWdURaa1E2cU5Ubm1Cc0VEaENiTGRIQlJsUGxKN3ZOal9pbGhCV0cwMzF4U2x0aWVOQWRwV1Nld3ZZN0tXUDE1SmxfaE9hazgxYzlRN0dmXzUxZlF3cTZZZXBEYm5NQQ?oc=5","date":"2013-08-30","type":"pipeline","source":"PMLiVE","summary":"ReNeuron wins orphan status for stem cell therapy - PMLiVE","headline":"ReNeuron wins orphan status for stem cell therapy","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}